content top

Change in Subfoveal Choroidal Thickness After PASCAL Laser Panretinal Photocoagulation

Hee Seong Yoon_SCIENTIFIC POSTER 2015 Purpose: To evaluate changes in subfoveal choroidal thickness (SFCT) after Pattern Scan Laser (PASCAL) panretinal photocoagulation (PRP) in patients with diabetic retinopathy. Methods: This study included 39 patients (50 eyes) treated with PRP using PASCAL then followed for at least 3 months. Patients were classified into 2 groups according to severity: very severe non-proliferative diabetic retinopathy...

Read More

Pattern Scan Laser vs Conventional Panretinal Photocoagulation in PDR

Poster Tae Gon Lee Purpose: To compare the clinical results of pattern scan laser (PASCAL) versus conventional panretinal photocoagulation (PRP) for the management of proliferative diabetic retinopathy (PDR). Methods: Retrospective review of the medical records was performed on 379 consecutive eyes with newly diagnosed PDR that underwent PRP using either PASCAL (160 eyes treated between June 2008 and April 2011) or conventional laser (219...

Read More

Subthreshold Diode Micropulse Panretinal Photocoagulation for Proliferative Diabetic Retinopathy

Jeffrey K. Luttrull, MD (Ventura, CA), David C. Musch, PhD (Ann Arbor, MI),* Charles A. Spink, CRA (Ventura, CA) PURPOSE: To report the visual and clinical outcomes of a pilot study of subthreshold diode micropulse (SDM) panretinal photocoagulation (PRP) for treatment of diabetic retinopathy. METHODS: A retrospective chart review of all patients undergoing PRP for complications of diabetic retinopathy between April 2000 and February 2003...

Read More

A Simple Predictor of VitraseĀ® Efficacy for Successful Laser Treatment in Patients with Diabetes and Severe Vitreous Hemorrhage

Abdhish R. Bhavsar, MD (Minneapolis, MN),* Maurice B. Landers, MD, FACS (Chapel Hill, NC),* Ronald K. Pearson, PhD (Harrisburg, PA),* Alan M. Hochberg, BSE (Harrisburg, PA),* Timothy R. McNamara, Pharm D (Irvine, CA),* James A. Gow, MD (Irvine, CA),* Lisa R. Grillone, PhD (Irvine, CA)* PURPOSE: To develop and validate a method of predicting by one month post-intravitreous injection whether subjects receiving VitraseĀ® (lyophilized, ovine...

Read More
content top